v3.25.2
Consolidated Statements of Shareholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Loss, Net of Tax
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2023   72,516,079        
Balance at beginning of period at Dec. 31, 2023 $ 3,426,747 $ 72,516 $ 1,945,385 $ 1,539,957 $ (35,939) $ (95,172)
Balance at beginning of period (in shares) at Dec. 31, 2023           3,462,738
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   125,832        
Issuance of restricted shares 0 $ 126 (126)      
Forfeitures of restricted shares (in shares)   (8,003)        
Forfeitures of restricted shares (181) $ (8) (173)      
Issuance of common shares pursuant to PSU agreements (in shares)   63,301        
Issuance of common shares pursuant to PSU agreements   $ 63 (63)      
Share-based compensation 5,823   5,823      
Purchase of treasury shares (in shares)           167,898
Purchase of treasury shares (7,955)         $ (7,955)
Net income 165,097     165,097    
Dividends on common shares (20,836)     (20,836)    
Other comprehensive income (loss) during the period (2,081)       (2,081)  
Balance at end of period (in shares) at Jun. 30, 2024   72,697,209        
Balance at end of period at Jun. 30, 2024 3,566,614 $ 72,697 1,950,846 1,684,218 (38,020) $ (103,127)
Balance at end of period (in shares) at Jun. 30, 2024           3,630,636
Balance at beginning of period (in shares) at Mar. 31, 2024   72,683,199        
Balance at beginning of period at Mar. 31, 2024 3,484,738 $ 72,683 1,948,352 1,603,832 (39,959) $ (100,170)
Balance at beginning of period (in shares) at Mar. 31, 2024           3,567,936
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   22,013        
Issuance of restricted shares 0 $ 22 (22)      
Forfeitures of restricted shares (in shares)   (8,003)        
Forfeitures of restricted shares (181) $ (8) (173)      
Share-based compensation 2,689   2,689      
Purchase of treasury shares (in shares)           62,700
Purchase of treasury shares (2,957)         $ (2,957)
Net income 90,785     90,785    
Dividends on common shares (10,399)     (10,399)    
Other comprehensive income (loss) during the period 1,939       1,939  
Balance at end of period (in shares) at Jun. 30, 2024   72,697,209        
Balance at end of period at Jun. 30, 2024 $ 3,566,614 $ 72,697 1,950,846 1,684,218 (38,020) $ (103,127)
Balance at end of period (in shares) at Jun. 30, 2024           3,630,636
Balance at beginning of period (in shares) at Dec. 31, 2024 72,699,245 72,699,245        
Balance at beginning of period at Dec. 31, 2024 $ 3,751,522 $ 72,699 1,958,642 1,853,428 (30,119) $ (103,128)
Balance at beginning of period (in shares) at Dec. 31, 2024 3,630,636         3,630,636
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   88,841        
Issuance of restricted shares $ 0 $ 88 (88)      
Forfeitures of restricted shares (in shares)   (13,619)        
Forfeitures of restricted shares (417) $ (13) (404)      
Issuance of common shares pursuant to PSU agreements (in shares)   122,904        
Issuance of common shares pursuant to PSU agreements 0 $ 123 (123)      
Share-based compensation 6,869   6,869      
Purchase of treasury shares (in shares)           555,692
Purchase of treasury shares (33,594)         $ (33,594)
Net income 197,769     197,769    
Dividends on common shares (27,704)     (27,704)    
Other comprehensive income (loss) during the period $ 23,233       23,233  
Balance at end of period (in shares) at Jun. 30, 2025 72,897,371 72,897,371        
Balance at end of period at Jun. 30, 2025 $ 3,917,678 $ 72,897 1,964,896 2,023,493 (6,886) $ (136,722)
Balance at end of period (in shares) at Jun. 30, 2025 4,186,328         4,186,328
Balance at beginning of period (in shares) at Mar. 31, 2025   72,884,780        
Balance at beginning of period at Mar. 31, 2025 $ 3,823,802 $ 72,885 1,961,732 1,927,489 (14,430) $ (123,874)
Balance at beginning of period (in shares) at Mar. 31, 2025           3,973,856
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   12,591        
Issuance of restricted shares 0 $ 12 (12)      
Share-based compensation 3,176   3,176      
Purchase of treasury shares (in shares)           212,472
Purchase of treasury shares (12,848)         $ (12,848)
Net income 109,834     109,834    
Dividends on common shares (13,830)     (13,830)    
Other comprehensive income (loss) during the period $ 7,544       7,544  
Balance at end of period (in shares) at Jun. 30, 2025 72,897,371 72,897,371        
Balance at end of period at Jun. 30, 2025 $ 3,917,678 $ 72,897 $ 1,964,896 $ 2,023,493 $ (6,886) $ (136,722)
Balance at end of period (in shares) at Jun. 30, 2025 4,186,328         4,186,328